| Accession |
PRJCA022404 |
| Title |
A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma |
| Relevance |
Medical |
| Data types |
PD-L1 IHC Data
|
| Organisms |
Homo sapiens
|
| Description |
The study enrolled 479 participants to receive CS1001+CAPOX or Placebo+CAPOX treatment. Compare Analyzed data in these two groups to verify the efficiency and safety. |
| Sample scope |
Multiisolate |
| Release date |
2024-01-31 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| CStone Pharmaceutical Suzhou Co., Ltd
|
|
N/A
|
|
|
|
| Submitter |
Lu
Liu (liulu@cstonepharma.com)
|
| Organization |
Beijing Cancer Hospital |
| Submission date |
2023-12-25 |
